Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New factor Xa/factor VIIa inhibitors in early development at Merck

Aug. 5, 2002

Potential new therapeutic agent for arterial thrombosis discovered in Taiwan

Aug. 5, 2002

Novel antithrombin agents prepared and tested at Servier

Aug. 2, 2002

Bivalirudin + abciximab for percutaneous coronary revascularization

Aug. 2, 2002

Aventis describes novel factor Xa/VIIa inhibitors and their use

Aug. 1, 2002

Arixtra launched in Germany for preventing VTEs

July 31, 2002

Major European launch for Otsuka antithrombotic agent

July 31, 2002

Thrombin receptor antagonists designed at Merck

July 26, 2002

New antithrombin agents designed by AstraZeneca scientists

July 23, 2002

Yamanouchi scientists design series of anticoagulants

July 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...